4.7 Review

Tumor organoids: applications in cancer modeling and potentials in precision medicine

Journal

JOURNAL OF HEMATOLOGY & ONCOLOGY
Volume 15, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13045-022-01278-4

Keywords

Organoid; Patient-derived xenografts; Cancer; Tumor microenvironment; Therapy response prediction; Drug discovery

Funding

  1. National Natural Science Foundation of China [81874120, 82073370]

Ask authors/readers for more resources

Cancer is a life-threatening disease with intratumor heterogeneity. Personalized tumor models capturing individual patients' tumor heterogeneity are urgently needed for precision medicine. Organoid technology, which can generate three-dimensional tissues that accurately recapitulate the characteristics of primary tumors, has shown great potential in accurately modeling cancer. Tumoroids serve as a valuable tool for the discovery of therapeutic targets, prediction of treatment response, and exploration of potential therapies.
Cancer is a top-ranked life-threatening disease with intratumor heterogeneity. Tumor heterogeneity is associated with metastasis, relapse, and therapy resistance. These factors contribute to treatment failure and an unfavorable prognosis. Personalized tumor models faithfully capturing the tumor heterogeneity of individual patients are urgently needed for precision medicine. Advances in stem cell culture have given rise to powerful organoid technology for the generation of in vitro three-dimensional tissues that have been shown to more accurately recapitulate the structures, specific functions, molecular characteristics, genomic alterations, expression profiles, and tumor microenvironment of primary tumors. Tumoroids in vitro serve as an important component of the pipeline for the discovery of potential therapeutic targets and the identification of novel compounds. In this review, we will summarize recent advances in tumoroid cultures as an excellent tool for accurate cancer modeling. Additionally, vascularization and immune microenvironment modeling based on organoid technology will also be described. Furthermore, we will summarize the great potential of tumor organoids in predicting the therapeutic response, investigating resistance-related mechanisms, optimizing treatment strategies, and exploring potential therapies. In addition, the bottlenecks and challenges of current tumoroids will also be discussed in this review.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available